Industry News
International research team formed to make impact on clinical care for prostate cancer patients
Dec 03, 2014
An international team has been formed to help quickly determine life-threatening cases of prostate cancer compared with cancer that may not require treatment. Read More
Prescriptions for drugs to strengthen bones remain low despite recommended use for men receiving androgen deprivation therapy
Dec 03, 2014
Although some guidelines recommend use of bisphosphonates (a class of drugs used to strengthen bone) for men on androgen deprivation therapy, an analysis finds that prescriptions for these drugs... Read More
Stressing out cancer cells may lead to better treatment
Dec 03, 2014
Using metabolic stress to kill cancer cells could open the way for new targeted therapies that won't harm normal cells and have no adverse side effects. Read More
New data shows popular alternative medicines can pose a risk to cancer patients
Dec 03, 2014
The ten most commonly asked about complementary medicines all interact with conventional treatments, potentially posing a threat to patient health and reaffirming the need for complementary or... Read More
Improvement in UK cancer survival over 40 years overshadowed by low survival for brain, stomach, lung, oesophageal, and pancreatic cancers
Dec 03, 2014
Remarkable improvements in cancer survival mean that half of all people diagnosed with cancer today (2010-11) in England and Wales are expected to survive from their cancer for at least 10 years... Read More
Acid reflux medicines improve survival for patients with head and neck squamous cell carcinoma
Dec 03, 2014
Patients with head and neck squamous cell carcinoma (HNSCC) who were taking a proton-pump inhibitor and/or a histamine receptor-2 antagonist to alleviate acid reflux had longer overall survival... Read More
Prognostic role found for miR-21 expression in triple-negative breast cancer
Dec 03, 2014
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-). Read More
BC Cancer Agency scientists make internationally significant discovery, mapping the evolution of breast cancer 'avatars'
Dec 03, 2014
A just-published paper in the prestigious journal Nature highlights how researchers at the BC Cancer Agency are using human breast cancer 'avatars' - models of human breast cancers - to measure how... Read More
Majority of people ignore cancer warning signs, study finds
Dec 03, 2014
Most people who experience warning signs of cancer dismiss them as being symptoms of less serious conditions, finds a new study by researchers from the UK. Read More
Breast, lung and colon cancers may be prevented by widely used osteoporosis drugs
Dec 03, 2014
The most commonly used medications for osteoporosis worldwide, bisphosphonates, may also prevent certain kinds of lung, breast and colon cancers, according to two studies led by researchers at the... Read More
Previous Page Next Page